Last Updated : Friday, July 3, 2020 16:47:30

Tag Archives: Cadila Healthcare

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

CADILA HEALTH ink pact with GILEAD SCIENCES to mfr & mkt REMDESIVIR

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges from Ahmedabad headquartered Pankaj Patel led Zydus Group’s Healthcare Services providing, Pharmaceutical and Wellness products manufacturing Indian company Cadila Healthcare Ltd it said of having inked non-exclusive licensing agreement with Gilead Sciences Inc., to manufacture and market Remdesivir

(ZYDUS) CADILA HEALTH gets USFDA nod to sell medicine to treat HIV

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led healthcare services providing and pharmaceutical as well as wellness products manufacturing group Zydus Cadila’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell

(ZYDUS) CADILA HEALTH explores biological route to treat Corona Virus

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr. Pankaj Patel led healthcare, pharmaceutical and wellness product manufacturing Zydus Cadila Group’s – pharma arm Cadila Healthcare Ltd said of exploring biological route to treat corona virus, which is based on the data and observations

ZYDUS CADILA gets USFDA nod to sell tablets to treat Diabetis, Heart Diseases

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical, healthcare & wellness enterprise – Dr Pankaj Patel led Zydus Cadila Group’s healthcare arm – Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to market tablets in dosage value

CADILA HEALTH gets USFDA nod to sell tablets to treat cancer conditions

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Cadila Group’s – Cadila Healthcare Ltd said of having got final approval from USFDA (US Food and Drugs Administration) for tablet to treat several types of cancer. In a press-release titled,

ZYDUS CADILA’s Diabetic treatment drug gets nod from Indian Drug Regulator

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Group company Cadila Healthcare Ltd said of having got approval from Drug Controller General of India (DCDI) for Saroglitazar Magnesium for treatment of diabetes. To read more, please CLICK here. Long Read

CADILA inks licensing agreement to market Anemia treatment in China

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical products manufacturing company Cadila Healthcare Ltd said of having entered into licensing agreement with China Medical System Holdings for marketing anemia treatment in Greater China. The press-release titled, “Zydus and China Medical System Holdings enter

CADILA HEALTH (ZYDUS) gets USFDA nod to market medicine for cardiac cure & skin treatment

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel lead Zydus Cadila Group) said of having got nod from USFDA (US Food & Drugs Administration) to market medicines to cure cardiac problems and skin-treatment. In a press-release as submitted by

CADILA HEALTH (ZYDUS) announces 2nd Phase-3 trials for a nephrology product

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Group) announced second phase-3 trials of Desidustat, medicine used to treat patients with kidney disease and kidney related disorders. In a press-release as submitted by the company to the

Cadila gets USFDA nod to market blood-pressure, heart disease treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharma major Cadila Healthcare Ltd (Dr. Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market tablets to treat blood-pressure and heart disease. The press-statement, as addressed by

Zydus Cadila gets USFDA nod to market sedative/hypnotic (sleep disorder treatment drug)

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses, Ahmedabad headquartered Dr. Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat insomnia (sleep related disorders) The press release submitted by the company

Zydus Cadila completes 3-phased clinical trial enrollment for drug, to cure liver disorder

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) said of having completed enrollment for three phase clinical trials of drug used to treat the a progressive disease of the liver – NASH. The press release submitted to the Indian

Zydus Cadila gets USFDA nod to market high blood-pressure treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Stock Exchanges in India on Monday, Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare) said of having received the final approval from the USFDA (United States Food & Drugs Administration) to market Chlorthalidone Tablets USP (US RLD – THALITONE@),25 mg and 50 mg.

Zydus Cadila (Healthcare) gets USFDA nod to market anti-epileptic drug to prevent & control seizures

AHMEDABAD-GANDHINAGAR | MUMBAI | RAJKOT – In a press-release submitted to the Indian Bourses on Monday, Ahmedabad headquartered pharma major – Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) has received the tentative approval from the USFDA to market Lacosamide Tablets (US RLD – Vimpat®) in the strengths of 50 mg, 100 mg,

Do NOT follow this link or you will be banned from the site!